ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 89 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $153,000 | -45.6% | 74,256 | +7.4% | 0.00% | 0.0% |
| Q4 2021 | $281,000 | -10.8% | 69,140 | +13.6% | 0.00% | -50.0% |
| Q3 2021 | $315,000 | +21.6% | 60,848 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $259,000 | -36.5% | 60,848 | -20.9% | 0.00% | -66.7% |
| Q1 2021 | $408,000 | +48.9% | 76,920 | +51.1% | 0.00% | +50.0% |
| Q4 2020 | $274,000 | +122.8% | 50,907 | +77.9% | 0.00% | -33.3% |
| Q1 2019 | $123,000 | -12.8% | 28,621 | +8.7% | 0.00% | -25.0% |
| Q4 2018 | $141,000 | -5.4% | 26,341 | +139.9% | 0.00% | +33.3% |
| Q3 2018 | $149,000 | – | 10,980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Matrix Capital Management Company, LP | 38,974,185 | $166,030,000 | 1.81% |
| Endurant Capital Management LP | 1,539,435 | $6,558,000 | 1.80% |
| NEA Management Company, LLC | 17,082,611 | $72,772,000 | 0.95% |
| PFM Health Sciences, LP | 3,627,900 | $15,455,000 | 0.48% |
| GSA CAPITAL PARTNERS LLP | 513,388 | $2,187,000 | 0.25% |
| Baker Brothers Advisors | 9,830,877 | $41,880,000 | 0.18% |
| Avoro Capital Advisors LLC | 2,024,400 | $8,624,000 | 0.15% |
| Vigilare Wealth Management | 54,250 | $231,000 | 0.14% |
| AlphaCentric Advisors LLC | 120,000 | $511,000 | 0.14% |
| Rock Springs Capital Management LP | 1,545,000 | $6,582,000 | 0.13% |